Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating ndrg2 expression in breast cancer cells

37Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

The N-myc downstream-regulated gene 2 (NDRG2) is involved in tumor cell differentiation and apoptosis, but its function in tumor angiogenesis remains to be established. Here, we employed adenovirus overexpressing NDRG2 (Ad-NDRG2) to efficiently up-regulate target gene expression in the NDRG2-low-expressing, breast cancer cell line MCF-7. Moreover, VEGF secretion was decreased in MCF-7 cells infected by Ad-NDRG2, and medium conditioned by these infected cells could significantly inhibit the proliferation, tube formation and invasion of human umbilical vein endothelial cells (HUVECs). Further study indicated that the angiogenesis promoting factors VEGF and HIF-1α were down-regulated, whereas the angiogenesis suppressing factors p53 and VHL were up-regulated in MCF-7 cells infected by Ad-NDRG2. Finally, in a nude mouse model, intratumoral injections of Ad-NDRG2 every 3 days for 20 days significantly inhibited the growth and angiogenesis of xenografted MCF-7 tumors. In summary, these data indicate that NDRG2 may be involved in angiogenesis by impacting the expression of angiogenesis related factors. Thus, specific overexpression of NDRG2 by adenovirus represents a promising approach for the treatment of tumor angiogenesis. © 2012 Ma et al.

Cite

CITATION STYLE

APA

Ma, J., Liu, W., Yan, X., Wang, Q., Zhao, Q., Xue, Y., … Zhang, J. (2012, February 29). Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating ndrg2 expression in breast cancer cells. PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0032368

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free